These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 12910681

  • 41. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
    Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH.
    Biochem Pharmacol; 2006 Apr 14; 71(8):1162-74. PubMed ID: 16499877
    [Abstract] [Full Text] [Related]

  • 42. [Effect of alpha-fetoprotein on the growth of human hepatoma cells in vitro].
    Wang XW, Xie H.
    Shi Yan Sheng Wu Xue Bao; 1999 Mar 14; 32(1):15-22. PubMed ID: 12548790
    [Abstract] [Full Text] [Related]

  • 43. Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
    Jia L, Xu H, Zhao Y, Jiang L, Yu J, Zhang J.
    Cancer Invest; 2008 Dec 14; 26(10):977-83. PubMed ID: 19093255
    [Abstract] [Full Text] [Related]

  • 44. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
    Chen XP, Wang Q, Guan J, Huang ZY, Zhang WG, Zhang BX.
    World J Gastroenterol; 2006 Jun 07; 12(21):3332-7. PubMed ID: 16733848
    [Abstract] [Full Text] [Related]

  • 45. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ, Bi H, Feng JQ, Cao JG.
    Acta Pharmacol Sin; 2005 Aug 07; 26(8):1009-16. PubMed ID: 16038636
    [Abstract] [Full Text] [Related]

  • 46. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I, Brisson C, Fabre M, Bergerat JP, Rebel G.
    Anticancer Res; 2008 Aug 07; 28(1A):55-68. PubMed ID: 18383825
    [Abstract] [Full Text] [Related]

  • 47. [Anti-tumor effects of bispecific monoclonal antibody targeted human monocytes-macrophages on hepatoma cells].
    Wang Q, Chen Z, Wang W.
    Zhonghua Yi Xue Za Zhi; 1996 Feb 07; 76(2):96-9. PubMed ID: 8758438
    [Abstract] [Full Text] [Related]

  • 48. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
    Djojosubroto MW, Chin AC, Go N, Schaetzlein S, Manns MP, Gryaznov S, Harley CB, Rudolph KL.
    Hepatology; 2005 Nov 07; 42(5):1127-36. PubMed ID: 16114043
    [Abstract] [Full Text] [Related]

  • 49. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 07; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 50. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
    Sun YL, Zhou GY, Li KN, Li WT, Song XR, Gao P.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 02; 85(8):518-21. PubMed ID: 15949329
    [Abstract] [Full Text] [Related]

  • 51. [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma].
    Zhu RX, Lin JS, Song YH, Li PY, Tao LW.
    Zhonghua Zhong Liu Za Zhi; 2006 Apr 02; 28(4):261-4. PubMed ID: 16875623
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Altered subcellular distribution of daunorubicin in the non-P-glycoprotein-mediated multidrug-resistant cell line HL-60/ADR].
    Gong Y, Wang Y, Chen F, Han J, Shao N, Fang Z, Ouyang R.
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jun 02; 21(6):309-11, 2. PubMed ID: 11876999
    [Abstract] [Full Text] [Related]

  • 54. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells.
    Wu J, Wang YS, Yang XY, Liu YY, Yang JR, Yang R, Zhang N.
    Nanotechnology; 2012 Sep 07; 23(35):355101. PubMed ID: 22875697
    [Abstract] [Full Text] [Related]

  • 55. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
    Shao RP.
    Zhonghua Zhong Liu Za Zhi; 1986 Jul 07; 8(4):259-61. PubMed ID: 3019621
    [Abstract] [Full Text] [Related]

  • 56. Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization.
    Lou PJ, Lai PS, Shieh MJ, Macrobert AJ, Berg K, Bown SG.
    Int J Cancer; 2006 Dec 01; 119(11):2692-8. PubMed ID: 16991130
    [Abstract] [Full Text] [Related]

  • 57. [Cytotoxicity to hepatoma BEL-7402 cells of an antitumor monoclonal antibody-streptonigrin conjugate].
    Liu Y, Wu J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Jun 01; 15(3):212-6. PubMed ID: 8222008
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effects of lidamycin on genomic DNA in human hepatoma BEL-7402 cells.
    He QY, Jiang B, Li DD.
    Acta Pharmacol Sin; 2002 Mar 01; 23(3):253-6. PubMed ID: 11918851
    [Abstract] [Full Text] [Related]

  • 60. Fabrication of novel hepatoma-targeting microdisks by hydrogen bond-assisted self-assembly of an azacitidine-conjugating amphiphilic random copolymer.
    Li X, Guo H, Wang J, Wu Q, Lin X.
    Acta Biomater; 2010 Feb 01; 6(2):511-8. PubMed ID: 19596092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.